- Home
- TLSI vs EUDA Comparison
TLSI vs EUDA Comparison
Compare TLSI & EUDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- EUDA
- Stock Information
- Founded
- TLSI 2010
- EUDA 2021
- Country
- TLSI United States
- EUDA Singapore
- Employees
- TLSI N/A
- EUDA N/A
- Industry
- TLSI Medical Specialities
- EUDA Blank Checks
- Sector
- TLSI Health Care
- EUDA Finance
- Exchange
- TLSI Nasdaq
- EUDA Nasdaq
- Market Cap
- TLSI 204.0M
- EUDA 146.0M
- IPO Year
- TLSI N/A
- EUDA N/A
- Fundamental
- Price
- TLSI $5.04
- EUDA $3.30
- Analyst Decision
- TLSI Strong Buy
- EUDA
- Analyst Count
- TLSI 5
- EUDA 0
- Target Price
- TLSI $10.90
- EUDA N/A
- AVG Volume (30 Days)
- TLSI 155.6K
- EUDA 93.4K
- Earning Date
- TLSI 08-13-2025
- EUDA 01-01-0001
- Dividend Yield
- TLSI N/A
- EUDA N/A
- EPS Growth
- TLSI N/A
- EUDA N/A
- EPS
- TLSI N/A
- EUDA N/A
- Revenue
- TLSI $32,141,000.00
- EUDA $4,011,005.00
- Revenue This Year
- TLSI $55.52
- EUDA $212.19
- Revenue Next Year
- TLSI $54.76
- EUDA $254.35
- P/E Ratio
- TLSI N/A
- EUDA N/A
- Revenue Growth
- TLSI 46.20
- EUDA 8.22
- 52 Week Low
- TLSI $3.50
- EUDA $2.92
- 52 Week High
- TLSI $6.04
- EUDA $6.30
- Technical
- Relative Strength Index (RSI)
- TLSI 45.84
- EUDA 41.59
- Support Level
- TLSI $4.78
- EUDA $3.35
- Resistance Level
- TLSI $5.20
- EUDA $3.60
- Average True Range (ATR)
- TLSI 0.31
- EUDA 0.15
- MACD
- TLSI -0.03
- EUDA -0.02
- Stochastic Oscillator
- TLSI 30.29
- EUDA 0.00
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About EUDA EUDA Health Holdings Limited
EUDA Health Holdings Ltd is a non-invasive healthcare company across Southeast Asia and China. The Company has two reportable segments: property management services and holistic wellness consumer products and services. Key revenue is generated from property management services that include common area property management services that contain cleaning, landscaping, public facilities maintenance and other traditional services and also include security property management services provided to all tenants and property owners.